Depression and Cardiovascular Disease: The Safety of Antidepressant Drugs and their Ability to Improve Mood and Reduce Medical Morbidity

Depression and Heart Disease

Volumn , Issue , 2010, Pages 125-143

  Glassman, Alexander H ^a,b   Bigger, J Thomas ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

cardiovascular disease (CVD); cognitive behavioural therapy (CBT); Depression and Cardiovascular Disease: The Safety of Antidepressant Drugs and their Ability to Improve Mood and Reduce Medical Morbidity; Implementing Treatment of Depression in a Medical Setting; left ventricular ejection fraction (LVEF); National Heart, Lung, and Blood Institute (NHLBI); selective serotonin reuptake inhibitors (SSRIs); Sertraline Antidepressant Heart Attack Randomised Trial (SADHART); The Ability of Antidepressant Drugs to Influence Medical Morbidity and Mortality; The Safety of Antidepressant Drugs

Indexed keywords

EID: 84886105552     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470972304.ch5     Document Type: Chapter

References (46)

1. Anda, R., Williamson, D., Jones, D. et al. (1993) Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of United States adults. Epidemiology, 4, 285-293.
2. Murphy, J. (1990) Depression in the community: findings from the Stirling County Study. Can. J. Psychiatry, 35, 390-396.
3. Carney, R.M., Rich, M.W., Freedland, K.E., et al. (1988) Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom. Med., 50, 627-633.
4. Frasure-Smith, N., Lesperance, F. and Talajic, M. (1993) Depression following myocardial infarction. Impact on 6-month survival. JAMA, 270, 1819-1825.
5. Bush, D.E., Ziegelstein, R.C., Patel, U.V., et al. (2005) Post-Myocardial Infarction Depression, Agency for Health Research and Quality, Rockville.
6. Wulsin, L.R. and Singal, B.M. (2003) Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom. Med., 65, 201-210.
7. Roose, S.P., Glassman, A.H., Attia, E. and Woodring, S. (1994) Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am. J. Psychiatry, 151, 1735-1739.
8. Roose, S.P., Glassman, A.H., Attia, E. et al. (1998) Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am. J. Psychiatry, 155, 660-665.
9. Glassman, A.H., O'Connor, C.M., Califf, R.M. et al. (2002) Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA, 288, 701-709.
10. Shapiro, P.A., Lesperance, F., Frasure-Smith, N. et al. (1999) An openlabel preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti- Depressant Heart Attack Trial. Am. Heart J., 137, 1100-1106.
11. Strik, J.J., Honig, A., Lousberg, R. et al. (2000) Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom. Med., 62, 783-789.
12. Berkman, L.F., Blumenthal, J., Burg, M. et al. (2003) Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA, 289, 3106-3116.
13. Beck, A.T., Rush, A.J., Shaw, B.F. and Emory, G. (1979) Cognitive Therapy for Depression, Guilford, New York.
14. Taylor, C.B., Youngblood, M.E., Catellier, D. et al. (2005) Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch. Gen. Psychiatry, 62, 792-798.
15. Glassman, A.H., Bigger, J.T. Jr and Gaffney, M. (2009) Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch. Gen. Psychiatry, 66, 1022-1029.
16. Honig, A., Kuyper, A.M., Schene, A.H. et al. (2007) Treatment of post-myocardial infarction depressive disorder: a randomized, placebocontrolled trial with mirtazapine. Psychosom. Med., 69, 606-613.
17. Tiihonen, J., Lonnqvist, J., Wahlbeck, K. et al. (2006) Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch. Gen. Psychiatry, 63, 1358-1367.
18. Glassman, A.H., Bigger, J.T. and Gaffney, M. (2006) Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch. Gen. Psychiatry, 63, 283-288.
19. Glassman, A.H. and Bigger, J.T. Jr (2007) Antidepressants in coronary heart disease: SSRIs reduce depression, but do they save lives?. JAMA, 297, 411-412.
20. Skala, J.A., Freedland, K.E. and Carney, R.M. (2006) Coronary heart disease and depression: a review of recent mechanistic research. Can. J. Psychiatry, 51, 738-745.
21. Carney, R.M., Freedland, K.E., Eisen, S.A. et al. (1995) Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol., 14, 88-90.
22. Ziegelstein, R.C., Fauerbach, J.A., Stevens, S.S. et al. (2000) Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch. Intern. Med., 160, 1818-1823.
23. Holtrop, J.S., Stommel, M., Corser, W. and Holmes-Rovner, M. (2009) Predictors of smoking cessation and relapse after hospitalization for acute coronary syndrome. J. Hosp. Med., 4, E3-E9.
24. Casey, E., Hughes, J.W., Waechter, D. et al. (2008) Depression predicts failure to complete phase-II cardiac rehabilitation. J. Behav. Med., 31, 421-431.
25. DiMatteo, M.R., Lepper, H.S. and Croghan, T.W. (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med., 160, 2101-2107.
26. Mukherjee, D., Fang, J., Chetcuti, S. et al. (2004) Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation, 109, 745-749.
27. Rieckmann, N., Gerin, W., Kronish, I.M. et al. (2006) Course of depressive symptoms and medication adherence after acute coronary syndromes - An electronic medication monitoring study. J. Am. Coll. Cardiol., 48, 2218-2222.
28. Glassman, A.H., Bigger, J.T., Gaffney, M. and Van Zyl, L.T. (2007) Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement. Arch. Gen. Psychiatry, 64, 1025-1031.
29. Glassman, A.H., Roose, S.P. and Bigger, J.T. Jr (1993) The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA, 269, 2673-2675.
30. Carney, R.M., Freedland, K.E., Steinmeyer, B. et al. (2008) Depression and five year survival following acute myocardial infarction: a prospective study. J. Affect. Disord., 109, 133-138.
31. Lesperance, F., Fräsure-Smith, N., Talajic, M. and Bourassa, M.G. (2002) Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation, 105, 1049-1053.
32. Glassman, A.H., Bigger, J.T. and Gaffney, M. (2009) Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression. Seven-year follow-up of SADHART participants. Arch. Gen. Psychiatry, 66, 1022-1029.
33. US. Preventive Services Task Force (2002) Screening for depression: recommendations and rationale. Ann. Intern. Med., 136, 760-764.
34. Lichtman, J.H., Bigger, J.T., Blumenthal, J.A. et al. (2008) Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research endorsed by the American Psychiatric Association. Circulation, 118, 1768-1775.
35. Kroenke, K., Spitzer, R.L. andWilliams, J.B. (2003) The Patient Health Questionnaire-2: validity of a two-item depression screener. Med. Care, 41, 1284-1292.
36. Alexopoulos, G.S., Reynolds, C.F. 3rd, Bruce, M.L. et al. (2009) Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study. Am. J. Psychiatry, 166, 882-890.
37. Rollman, B.L., Belnap, B.H., Lemenager, M.S. et al. (2009) Telephonedelivered collaborative care for treating post-CABG depression: a randomized controlled trial. JAMA, 302, 2095-2103.
38. Haukka, J., Arffman, M., Partonen, T. et al. (2009) Antidepressant use and mortality in Finland: a register-linkage study from a nationwide cohort. Eur. J. Clin. Pharmacol., 65, 715-720.
39. Gasse, C., Christensen, S., Riis, A. et al. (2009) Preadmission use of SSRIs alone or in combination with NSAIDs and 30-day mortality after peptic ulcer bleeding. Scand. J. Gastroenterol., 44, 1288-1295.
40. Kim, D.H., Daskalakis, C., Whellan, D.J. et al. (2009) Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting. Am. J. Cardiol., 103, 1391-1395.
41. Glassman, A.H. and Davis, J.M. (1987) Overdose with tricyclic drugs. Psychiatr. Ann., 17, 410-411.
42. Glassman, A.H., Roose, S.P. and Bigger, J.T. Jr (1993) The safety of tricyclic antidepressants in cardiac patients - risk/benefit reconsidered. JAMA, 269, 2673-2675.
43. Roose, S.P., Laghrissi-Thode, F., Kennedy, J.S. et al. (1998) Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA, 279, 287-291.
44. Roger, V.L., Jacobsen, S.J., Weston, S.A. et al. (2002) Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann. Intern. Med., 136, 341-348.
45. Rosamond,W., Flegal, K., Furie, K. et al. (2008) Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 117, e25-e146.
46. Thombs, B.D., Bass, E.B., Ford, D.E. et al. (2006) Prevalence of depression in survivors of acute myocardial infarction. J. Gen. Intern. Med., 21, 30-38.